HRSA-22-061: Rural Communities Opioid Response Program – Behavioral Health Care Support
Closed
This grant is closed. A newer notice from the same program is forecast: Rural Maternity and Obstetrics Management Strategies Program (HRSA-27-047). Status: Expected deadline April 20, 2027. It is in our archive of Health Resources and Services Administration notices from 2022.
Health Resources and Services Administration offered grants of up to $500,000 to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expected to make about 26 awards worth $13.0 million in total. Applications closed on April 20, 2022.
From the official notice on Grants.gov, last changed March 30, 2022. Checked November 7, 2026.
- Award ceiling$500,000
- Total funding$13.0 million
- Expected awards26
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | January 18, 2022 |
|---|---|
| Deadline | April 20, 2022 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants include all domestic public or private, non-profit and for-profit, entities including, but not limited to, faith-based and community-based organizations, federally recognized tribes and tribal organizations, state governments, and private institutions of higher education. In addition to the 50 U.S. states, organizations in the District of Columbia, Guam, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, the U.S. Virgin Islands, the Federated State of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau may apply. The applicant organization may be located in an urban or rural area.
Is this a realistic fit?
- Past Rural Healthcare Services Programs awards averaged $487,643; this notice allows up to $500,000 per award.
- No cost sharing or match is required.
What the grant funds
The Rural Communities Opioid Response Program (RCORP) is a multi-year initiative by the Health Resources and Services Administration (HRSA) aimed at reducing the morbidity and mortality of substance use disorder (SUD), including opioid use disorder (OUD) in high-risk rural communities. This notice announces the opportunity to apply for funding under the RCORP–Behavioral Health Care Support (RCORP-BHS). RCORP-BHS will advance RCORP’s overall goal by improving access to and quality of SUD and other behavioral health care services in rural communities. For the purposes of this NOFO, improving rural behavioral health care service delivery includes increasing access to and utilization of prevention, treatment and recovery services to improve the care for those affected by behavioral health conditions, which may include substance use and mental health disorders.
Who has won Rural Healthcare Services Programs grants before
From fiscal 2021 to 2025, Rural Healthcare Services Programs (93.912) awarded $727 million across 1,490 grant awards, an average of $487,643 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Rural Health Resource Center | Minnesota | 3 | $58.6 million |
| University of North Dakota | North Dakota | 3 | $10.3 million |
| JBS International, Inc. | Maryland | 1 | $10.1 million |
| Arkansas Rural Health Partnership | Arkansas | 6 | $8.3 million |
| Rural Health Redesign Center Organization, Inc. | Pennsylvania | 3 | $7.9 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-047, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-22-061 still open?
No. It closed on April 20, 2022. A newer notice is forecast: HRSA-27-047, expected deadline April 20, 2027.
Who can apply for Rural Communities Opioid Response Program – Behavioral Health Care Support?
Health Resources and Services Administration accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Rural Communities Opioid Response Program – Behavioral Health Care Support?
Closed April 20, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $500,000 each. About $13.0 million in total across about 26 awards.
Who has won Rural Healthcare Services Programs grants before?
The largest recipients over five fiscal years were Rural Health Resource Center, University of North Dakota, JBS International, Inc. The program made 1,490 awards worth $727 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)